Upside – $VEEA +45.0% (regained full Nasdaq listing compliance following its reverse stock split) – $XRTX +21.0% (outlined planned FDA IND and Health Canada clinical-trial filings for XRx-026 in gout) – $SAIQ +19.5% (confirmed an October satellite launch advancing its post-quantum secure-communications roadmap) – $HUM +14.5% (2027 CMS Star Ratings exceeded its top-quartile revenue goal, …
Read in context ›CVS Health Stock (CVS)
Track CVS Health stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
CVS
CVS Health
healthcare
At close
$86.16
▼ -1.64 (-1.87%)
Oct 9, 4:00 PM ET
After-hours
$86.47
▲ +0.31 (+0.36%)
Oct 9, 7:57 PM ET
Market Cap
$110.20B
P/E Ratio
22.8x
1Y Return
+15.84%
EPS (TTM)
$3.79
Read the latest TheStreet Pro articles mentioning CVS Health, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
45 articlesDaily Diary Mentions
1 mentionUpside, Downside Movers in the Morning



